We are live on ! Find out more
Cerity Partners

Cerity Partners Portfolio holdings

AUM $70.8B
1-Year Est. Return 21.68%
This Fund
S&P 500
This Quarter Est. Return
+0.96%
1 Year Est. Return
+21.68%
3 Year Est. Return
+64.34%
5 Year Est. Return
+67.23%
10 Year Est. Return
AUM
$46.1B
AUM Growth
+$931M
Cap. Flow
+$979M
Cap. Flow %
2.12%
Top 10 Hldgs %
25.92%
Holding
2,662
New
136
Increased
969
Reduced
1,202
Closed
246

Sector Composition

Rank Sector Weight
1 Technology 16.52%
2 Financials 7.81%
3 Healthcare 6.36%
4 Consumer Discretionary 5.15%
5 Consumer Staples 5.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
POWI icon
2201
Power Integrations
POWI
$3.15B
$216K ﹤0.01%
3,412
-2,253
-40% -$143K
IDCC icon
2202
InterDigital
IDCC
$6.75B
$216K ﹤0.01%
1,347
-277
-17% -$48.4K
ARQ icon
2203
Arq
ARQ
$83.3M
$215K ﹤0.01%
+28,428
New +$187K
RNW icon
2204
ReNew
RNW
$2.18B
$215K ﹤0.01%
31,502
+400
+1% +$2.43K
COUR icon
2205
Coursera
COUR
$1.77B
$215K ﹤0.01%
25,539
+15,312
+150% +$118K
BWX icon
2206
State Street SPDR Bloomberg International Treasury Bond ETF
BWX
$1.31B
$215K ﹤0.01%
10,053
-214
-2% -$4.72K
MQY icon
2207
BlackRock MuniYield Quality Fund
MQY
$812M
$215K ﹤0.01%
18,646
-464
-2% -$5.82K
EPI icon
2208
WisdomTree India Earnings Fund ETF
EPI
$2.04B
$214K ﹤0.01%
4,726
+1
+0% +$47
LBRT icon
2209
Liberty Energy
LBRT
$2.79B
$214K ﹤0.01%
+10,957
New +$203K
COKE icon
2210
Coca-Cola Consolidated
COKE
$12.8B
$213K ﹤0.01%
1,650
-4,860
-75% -$608K
PRVA icon
2211
Privia Health
PRVA
$3.04B
$213K ﹤0.01%
11,626
-2,095
-15% -$41.5K
VCLT icon
2212
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.81B
$213K ﹤0.01%
+2,848
New +$221K
CHH icon
2213
Choice Hotels
CHH
$5.26B
$212K ﹤0.01%
1,618
-387
-19% -$54.8K
CVE icon
2214
Cenovus Energy
CVE
$54.2B
$211K ﹤0.01%
12,851
-13,716
-52% -$221K
AMCX icon
2215
AMC Global Media
AMCX
$450M
$211K ﹤0.01%
21,734
+10,285
+90% +$91K
PHIN icon
2216
Phinia Inc
PHIN
$3.04B
$210K ﹤0.01%
4,513
-2,162
-32% -$107K
CYTK icon
2217
Cytokinetics
CYTK
$10.6B
$209K ﹤0.01%
4,066
-1,080
-21% -$56.1K
ORA icon
2218
Ormat Technologies
ORA
$5.8B
$209K ﹤0.01%
2,747
-2,749
-50% -$212K
WFC.PRL icon
2219
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.68B
$209K ﹤0.01%
175
-14
-7% -$17.2K
EXG icon
2220
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
EXG
$2.91B
$209K ﹤0.01%
25,572
RBRK icon
2221
Rubrik
RBRK
$14.8B
$209K ﹤0.01%
+3,196
New +$158K
IWX icon
2222
iShares Russell Top 200 Value ETF
IWX
$3.92B
$209K ﹤0.01%
2,641
UPST icon
2223
Upstart Holdings
UPST
$2.55B
$209K ﹤0.01%
+3,640
New +$227K
BRZE icon
2224
Braze
BRZE
$3.02B
$208K ﹤0.01%
+5,237
New +$190K
TDIV icon
2225
First Trust NASDAQ Technology Dividend Index Fund
TDIV
$4.05B
$208K ﹤0.01%
+2,649
New +$212K

Similar funds

Cerity Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Cerity Partners held 2,662 positions worth $46.1B, up 2.1% from $45.2B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Cerity Partners's Q4 2024 filing shows 136 new, 969 increased, 1,202 reduced and 246 closed positions. Its largest new stake was Avantis International Equity ETF: 670,740 shares worth $41.2M. The largest sale was iShares Ultra Short Duration Bond Active ETF, an estimated $78.4M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • Cerity Partners's largest Q4 2024 buy was Avantis International Equity ETF: 670,740 shares worth $41.2M.
  • Cerity Partners added most to Illinois Tool Works in Q4 2024, an estimated $174M increase.
  • Cerity Partners's biggest Q4 2024 reduction was iShares Ultra Short Duration Bond Active ETF, cutting an estimated $78.4M.
  • Cerity Partners fully exited Semler Scientific in Q4 2024, selling an estimated $31.7M.
  • Cerity Partners's ten largest holdings make up 26% of its $46.1B portfolio in Q4 2024.
  • Cerity Partners opened 136 new positions and closed 246 in Q4 2024.
  • Cerity Partners's portfolio value rose 2.1% quarter-over-quarter to $46.1B.

Based on Cerity Partners's 13F filing for Q4 2024, filed 13 Feb 2025.